• Info
  • Insider Ownership

Insider Trading & Ownership of Anna Protopapas

Location
Cambridge, MA
Summary
The estimated net worth of Anna Protopapas is at least $512,201 dollars as of 06 Jan 2026. Anna Protopapas is the Director of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $384.7K. Anna Protopapas is the Director of Dicerna Pharmaceuticals Inc and owns shares of Dicerna Pharmaceuticals Inc stock worth about $127.5K.
Signature
/s/ Anna Protopapas
All Insider Reports
All Insider Reports

Notify me when Anna Protopapas files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Anna Protopapas

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NUVL Nuvalent, Inc. Director $384,714 18 Jun 2025
DRNA Dicerna Pharmaceuticals Inc Director $127,487 03 Jun 2021
MRSN Mersana Therapeutics, Inc. Director $0 06 Jan 2026

Insider Transactions Reported by Anna Protopapas:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.